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In 2005, 329 cases of hepatitis E virus infection were 
conﬁ  rmed in England and Wales; 33 were conﬁ  rmed indig-
enous infections, and a further 67 were estimated to be in-
digenous infections. Hepatitis E should be considered in the 
investigation of patients with hepatitis even if they have no 
history of travel.
A
cute hepatitis caused by hepatitis E virus (HEV) has 
historically been considered an imported disease as-
sociated with travel to a disease-endemic area. However, 
an increasing number of sporadic hepatitis E cases not as-
sociated with travel have been reported from industrialized 
countries, including England and Wales (1).
Four HEV genotypes have been identiﬁ  ed that corre-
late with the geographic origin of the virus (2). Genotype 
1 is regularly identiﬁ  ed with disease-hyperendemic areas 
such as Africa and southern Asia; genotype 2, with Mexico 
and West Africa; genotype 3, with industrialized countries 
such as North America, Europe, and Japan; and genotype 
4, with eastern Asia and India.
The epidemiology of non–travel-associated hepatitis E 
is largely unknown. Although the main route of transmission 
in disease-hyperendemic areas is the consumption of fecally 
contaminated water, risk factors for HEV infection in non–
disease-hyperendemic countries have included occupational 
exposure to pigs (3) and consumption of raw or undercooked 
pork products (4), shellﬁ  sh (5), and venison (6).
HEV is endemic in pig populations worldwide (7), in-
cluding England and Wales, where HEV genotype 3 is wide-
spread in pigs, and subgenomic sequencing studies have 
shown a close relationship between pig and human HEV 
strains (8). Although zoonotic transmission from swine to 
humans appears plausible, the possibility of a reservoir com-
mon to both swine and humans cannot be excluded.
The Study
The reference laboratory for hepatitis E at the Health 
Protection Agency’s Centre for Infections reported 17 cases 
of non–travel-associated hepatitis E in England and Wales 
from 1996 through 2003 (5). During 2004, that laboratory 
and the other hepatitis E reference laboratory in Birming-
ham received an increased number of samples for HEV test-
ing with a corresponding increase in numbers of hepatitis E 
cases diagnosed by testing for HEV immunoglobulin (Ig) 
M and IgG by using ELISAs (Genelabs Technologies Inc, 
Redwood City, CA, USA). These observations led to this 
study, the aims of which were to describe the epidemiology 
of hepatitis E in England and Wales, estimate the number 
of non–travel-associated cases, and identify risk factors for 
HEV infection in indigenous cases.
During 2005, the reference laboratories conﬁ  rmed 329 
cases of acute hepatitis E infection. This number repre-
sented a substantial increase from 125 cases in 2003 and 
150 in 2004. Information on the age groups and sex of all 
patients who received a diagnosis during 2003, 2004, and 
2005 is shown in Figure 1. This ﬁ  gure shows a progressive 
increase in the number of acute cases of hepatitis E in older 
male patients over the period, and panel B demonstrates the 
overrepresentation of older men among those with estab-
lished indigenous cases during 2005 compared with those 
who were known travelers.
The travel history of the 329 patients is summarized 
in Figure 2. For 102 (31%) patients, pre-illness travel in-
formation was recorded on the laboratory request form. 
Travel status was obtained for 44 additional patients 
through follow-up, and 33 patients who had not traveled 
outside the United Kingdom were considered to be indig-
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Figure 1. A)  Age and sex distribution of acute hepatitis E patients, 
2003–2005 (n = 604). B) Age, sex distribution, and travel associated 
with indigenous acute hepatitis E case-patients (n = 143). NR, not 
recorded.
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 1, January 2008  165 enous case-patients. Twenty-three (70%) indigenous case-
patients were >55 years of age, compared to 26 (24%) of 110 
travel-associated case-patients; the median age was 65 
years (interquartile range [IQR] 50–74 years) and 41 years 
(IQR 29–54) (p<0.0001) respectively. Thirty-two of the in-
digenous case-patients (97%) had Caucasian names (name 
classiﬁ  cation was used as a proxy for ethnicity) compared 
with 21 (19%) of 110 travelers (p<0.001).
The number of indigenous HEV infections was esti-
mated for those with an unknown travel history by ﬁ  tting a 
logistical regression model that used Caucasian name and 
age as predictor variables. An estimated 67 (95% conﬁ  -
dence interval 58–75) of the 176 patients (when the date of 
birth was known) in this group acquired their infection in 
England and Wales.
Twenty-eight indigenous case-patients were available 
for telephone interview in which a detailed structured ques-
tionnaire was used to identify potential risk factors over the 
9-week period before illness. The Table summarizes the re-
sults obtained from responses. All patients were white, and 
23 (82%) were male, with a median age of 65 years. Twen-
ty (71%) were referred from southern England and Wales; 
a similar proportion of interviewed patients lived at inland 
or coastal addresses, and a high proportion of patients lived 
in densely populated urban areas. No common risk factors 
were identiﬁ  ed apart from 17 (60%) owning pets.
HEV RNA was detected in 14 of the 33 patients with 
indigenous hepatitis E, and all virus strains belonged to gen-
otype 3. All but one of the genotype 3 nucleotide sequences 
clustered with previously described strains from the United 
Kingdom and Europe. Three distinct sequence groups were 
noted, but subsequent detailed analysis showed no correla-
tion between these groups and geographic distribution or 
time, which indicated that a common source was unlikely.
Conclusions
The number of hepatitis E cases diagnosed in England 
and Wales began increasing substantially after 2004. In 
2005, acute hepatitis E was diagnosed in 329 patients; 33 of 
these deﬁ  nitely had acquired their infection in England and 
Wales, and a further 67 were estimated to have acquired 
their infection there. These ﬁ  gures may nevertheless be an 
underestimation since we also found that a high proportion 
of clinicians do not test for HEV unless the patient reports 
a recent history of travel to a disease-endemic area. This 
practice may be changing, and the progressive increase in 
the number of older patients with diagnoses of hepatitis E 
may reﬂ  ect a greater awareness among clinicians. Local in-
terest in hepatitis E may well explain the geographic distri-
bution of indigenous cases.
The demographic features of patients who acquired 
their infection in England and Wales are striking. Most pa-
tients were Caucasian men >55 years of age. These ﬁ  nd-
Figure 2. Details of cases of acute hepatitis E (HEV) infections, 
2005. *Contact with hepatitis E patients who recently returned from 
hyperendemic countries; †24-year-old woman infected with HEV 
genotype 1; ‡45-year-old Caucasian man who traveled to Iraq.
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Table. Main risk factors for cases of indigenous hepatitis E, 
England and Wales, 2005*
Risk factor 
Yes/ 
possibly  No
Residence
  Coastal address (<20 miles from sea)  15 13
  Urban area (>10,000 inhabitants)  27 1
Animal exposure 
  Occupation involving animal exposure  1 27
 Own  pets  17 11
 Live  on/visited  a  farm  4 24
Food preferences (i.e., likely to have consumed in the 9 weeks 
before onset of illness) 
 Pork  22 5
 Raw/undercooked  pork  0 27
 Pig  liver  7 19
  Raw/undercooked pig liver  0 26
 Venison  0 25
 Chicken  24 2
 Raw/undercooked  chicken  0 27
  Other meat (beef, lamb, turkey)  18 8
  Raw/undercooked other meat  4 21
 Fish  18 9
 Shellfish  5 22
Food preparation 
  Handle raw meat for cooking  13 15
 Wash  fruits  18 10
 Wash  vegetables  20 5
Drinking water supply 
 Mains  21 6
 Bottled  water  15 13
 River/stream  or  well  2 26
Recreational water exposure  5 23
 Dinghy  sailing  2 25
 Fishing  4 24
 Swimming  (pool)  1 26
*n = 28; some respondents did not answer all questions, so not all cells 
add up to 28. ings corroborate other studies in the literature (9). Possible 
reasons for this high attack rate in older adults remain un-
clear. Men infected with HEV are more likely to access 
healthcare than women in both disease-hyperendemic and 
non–disease-hyperendemic countries (5,10). Some re-
searchers have suggested that risk factors for disease may 
be linked to male occupational or societal roles (2). These 
unique demographic ﬁ  ndings need to be emphasized to the 
medical community because older Caucasian men may not 
be perceived as being at risk by physicians.
The epidemiology of hepatitis E in non–disease-en-
demic countries remains poorly understood, and the results 
from seroprevalence studies vary greatly, which suggests 
that commercially available serologic tests may not be 
reliable for population surveys on genotype 3 infections. 
Despite in-depth telephone interviews, we did not identify 
a likely common source of infection, and genotyping data 
suggest multiple sources of exposure to HEV. We found 
that 60% of patients reported owning pets, a higher propor-
tion than the proportion of animal-owning households in 
the United Kingdom for cats (25%) and dogs (21%) (11). 
Similar  ﬁ   ndings have been reported in the Netherlands 
(12). Although this difference might just reﬂ  ect the fact 
that pet ownership is higher among older persons, a high 
prevalence of anti-HEV antibodies has been found among 
dogs in India (13) and cats in Japan (14), and a patient with 
hepatitis E from Japan owned a pet cat who was positive 
for antibodies to HEV (15), all of which indicate that do-
mestic animals may be a potential reservoir for infection.
With the growing recognition of hepatitis E as an in-
creasingly important zoonotic infection in England and 
Wales, HEV should be considered an etiologic agent of 
acute and fulminant hepatitis even in patients who report 
no travel history. We need to raise awareness among health 
professionals to consider hepatitis E when investigating 
non–travel-associated cases of hepatitis.
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